Pathobiological Determinants of Atherosclerosis in Youth (PDAY)

This study has been completed.

First Received: May 25, 2000 Last Updated: January 18, 2008 History of Changes

Sponsor:	National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:	National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:	NCT00005679

Purpose

To conduct a multicenter prevalence survey for characterizing pathologically the extent of atherosclerosis in the aortas and coronary arteries of young persons dying from accidental causes, suicide, or homicide.

Condition	Phase
Cardiovascular Diseases Atherosclerosis Heart Diseases Coronary Disease Coronary Arteriosclerosis	N/A

Study Type:

Observational

Resource links provided by NLM:

MedlinePlus related topics: Coronary Artery Disease Heart Diseases

U.S. FDA Resources

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date:	June 1985
Study Completion Date:	July 1993
Primary Completion Date:	July 1993 (Final data collection date for primary outcome measure)

Show Detailed Description

Eligibility

Ages Eligible for Study:	15 Years to 34 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

No eligibility criteria

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005679

Sponsors and Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Investigators

Investigator:	Arthur Chandler	Medical College of Georgia
Investigator:	J. Cornhill	Ohio State University
Investigator:	J. Cornhill	Ohio State University
Investigator:	Asaad Daoud	Albany Medical College
Investigator:	Morton Friedman	Ohio State University
Investigator:	Steffen Gay	University of Alabama at Birmingham
Investigator:	James Hixson	Southwest Foundation for Biomedical Research
Investigator:	Singanallur Jagannathan	West Virginia University Medical Center
Investigator:	C. McMahan	University of Texas
Investigator:	C. McMahan	University of Texas
Investigator:	Wolfgang Mergner	University of Maryland
Investigator:	Wolfgang Mergner	University of Maryland
Investigator:	Edward Miller	University of Alabama at Birmingham
Investigator:	Stanley Radio	University of Nebraska
Investigator:	Dennis Reichebach	University of Washington
Investigator:	Abel Robertson	University of Illinois
Investigator:	Louis Smith	Baylor College of Medicine
Investigator:	Jack Strong	Louisiana State University Medical Center
Investigator:	Jack Strong	Louisiana State University Medical Center
Investigator:	Jack Strong	Louisiana State University Medical Center
Investigator:	Renu Virmani	Vanderbilt University School of Medicine
Investigator:	Renu Virmani	Vanderbilt University School of Medicine
Investigator:	Robert Wissler	University of Chicago
Investigator:	Robert Wissler	University of Chicago

Study ID Numbers:	1049
Study First Received:	May 25, 2000
Last Updated:	January 18, 2008
ClinicalTrials.gov Identifier:	NCT00005679 History of Changes
Health Authority:	United States: Federal Government